Lyell Immunopharma, Inc. (LYEL)

28.73 -2.05 (-6.66%) USD  |  NASDAQ  |  Jan 02, 16:00
28.73 0.00 (0.00%) After-Hours: 20:00
More

Lyell Immunopharma Quarterly Actual Revenue

Quarterly Actual Revenue Chart

View Quarterly Actual Revenue for LYEL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Quarterly Actual Revenue Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Quarterly Actual Revenue Range, Past 5 Years

View Quarterly Actual Revenue Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Quarterly Actual Revenue Benchmarks

View Quarterly Actual Revenue Benchmarks
Start Trial
Insmed, Inc. Upgrade
Nektar Therapeutics Upgrade
GT Biopharma, Inc. Upgrade
Ionis Pharmaceuticals, Inc. Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade